mediCAD Hectec GmbH has reached another milestone in the internationalization of its mediCAD® brand. Since mid of September, mediCAD® with its 2D and 3D modules has been approved as a medical device for the Japanese market.
mediCAD® is a worldwide known orthopedic planning solution for hip, knee, shoulder, hand, leg or spine surgery. Manual and automatic dimensioning, integrated implant templates, archiving of required information and a comprehensive traceability of findings in the preparation of operations and aftercare, make mediCAD demonstrably a software program with a high degree of planning and operation quality.
With the approval of mediCAD® as a medical device for the Japanese market as well as the recently closed sales partnership with TOYO Corporation, the company is now able to professionally, effectively and locally support hospitals and medical facilities in improving and digitizing the Japanese health care system.
The growing interest and need for digital planning software in Japan have increased dramatically in recent years and months. “With this approval, we now expect a clear demand for our product as well as an increase in growth on the Japanese market. We look forward to this new challenge,” states Jörn Seel, Managing Director of mediCAD Hectec GmbH.
mediCAD® is officially approved as medical device in around 30 countries inside and outside Europe. All European countries have approval and beside Japan, the company is allowed to sell mediCAD® in the United States, Brazil and Russia. “And we are continuously working on further country approvals such as e.g. South Africa or China”, says the Managing Director.
mediCAD® is a worldwide known orthopedic planning solution for hip, knee, shoulder, hand, leg or spine surgery. Manual and automatic dimensioning, integrated implant templates, archiving of required information and a comprehensive traceability of findings in the preparation of operations and aftercare, make mediCAD demonstrably a software program with a high degree of planning and operation quality.
With the approval of mediCAD® as a medical device for the Japanese market as well as the recently closed sales partnership with TOYO Corporation, the company is now able to professionally, effectively and locally support hospitals and medical facilities in improving and digitizing the Japanese health care system.
The growing interest and need for digital planning software in Japan have increased dramatically in recent years and months. “With this approval, we now expect a clear demand for our product as well as an increase in growth on the Japanese market. We look forward to this new challenge,” states Jörn Seel, Managing Director of mediCAD Hectec GmbH.
mediCAD® is officially approved as medical device in around 30 countries inside and outside Europe. All European countries have approval and beside Japan, the company is allowed to sell mediCAD® in the United States, Brazil and Russia. “And we are continuously working on further country approvals such as e.g. South Africa or China”, says the Managing Director.
